Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: Strain predominance, clustering, and polyclonal disease

Journal of Clinical Microbiology

Volumn 50, Issue 8, 2012, Pages 2645-2650

  Adams, Lisa V ^a   Kreiswirth, Barry N ^b   Arbeit, Robert D ^c   Soini, Hanna ^d   Mtei, Lillian ^e   Matee, Mecky ^e   Bakari, Muhammad ^e   Lahey, Timothy ^a   Wieland Alter, Wendy ^a   Shashkina, Elena ^b   Kurepina, Natalia ^b   Driscoll, Jeffrey R ^f,h   Pallangyo, Kisali ^e   Horsburgh, C Robert ^g   Von Reyna, C Fordham ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^f WADSWORTH CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; MYCOBACTERIUM ANTIGEN; PLACEBO;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CELLULAR IMMUNITY; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; POLYCLONAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPOLIGOTYPING; SPUTUM CULTURE; TANZANIA; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLUSTER ANALYSIS; COINFECTION; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TANZANIA; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84864409092     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00624-12     Document Type: Article

References (33)

1. Andrews JR, et al. 2012. Risk of progression to active tuberculosis following reinfection with M. tuberculosis. Clin. Infect. Dis. 54:784-791.
2. Badak FZ, et al. 1999. Use of nucleic acid probes for identification of Mycobacterium tuberculosis directly from MB/BacT bottles. J. Clin. Microbiol. 37:1602-1605. (Pubitemid 29187848)
3. Bifani PJ, et al. 1999. 1999. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 282:2321-2327. (Pubitemid 30013063)
4. Brander E. 1972. A simple way of detecting pyrazinamide resistance. Tubercle 53:128-131.
5. Chaves F, Dronda F, Alonso-Sanz M, Noriega AR. 1999. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS 13:615-620. (Pubitemid 29286728)
6. Chonde TM, et al. 2010. National anti-tuberculosis drug resistance study in Tanzania. Int. J. Tuberc. Lung Dis. 14:967-972.
7. Eldholm V, Matee M, Mfinanga SG, Heun M, Dahle UR. 2006. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol. 6:76.
8. Flahiff EW. 1939. The occurrence of tuberculosis in persons who failed to react to tuberculin, and in persons with positive tuberculin reactions. Am. J. Epidemiol. 30:69-74.
9. Garcia de Viedma D, Marin M, Serrano MJR, Alcala L, Bouza E. 2003. Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extra-respiratory involvement. J. Infect. Dis. 187:695-699. (Pubitemid 36250037)
10. Gillespie SH, et al. 1995. Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from patients with pulmonary tuberculosis in northern Tanzania. Trans. R. Soc. Trop. Med. Hyg. 89:335-338.
11. Glynn JR, et al. 2010. Changes in Mycobacterium tuberculosis genotype families over 20 years in a population-based study in Northern Malawi. PLoS One 5:e12259. doi:10.1371/journal.pone.0012259.
12. Glynn JR, et al. 2010. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J. Infect. Dis. 201:704-711.
13. Glynn JR, Vynnycky E, Fine PE. 1999. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am. J. Epidemiol. 149:366-371. (Pubitemid 29302110)
14. Glynn JR, et al. 2004. DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error? J. Infect. Dis. 190:1158-1166. (Pubitemid 39186804)
15. Gutacker MM, et al. 2006. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J. Infect. Dis. 193:121-128. (Pubitemid 43032507)
16. Houben RM, et al. 2011. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int. J. Tuberc. Lung Dis. 15:24-31.
17. Kato-Maeda M, Metcalfe JZ, Flores L. 2011. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol. 6:203-216.
18. Reference deleted.
19. Lawn SD, et al. 2010. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect. Dis. 10:489-498.
20. Reference deleted.
21. Mathema B, et al. 2002. Identification and evolution of an IS6110 low-copy-number Mycobacterium tuberculosis cluster. J. Infect. Dis. 185:641-649. (Pubitemid 34171469)
22. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. 2006. Molecular epidemiology of tuberculosis: current insights. Clin. Microbiol. Rev. 19: 658-685. (Pubitemid 44582976)
23. Middlekoop K, et al. 2009. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J. Infect. Dis. 200:1207-1211.
24. Munseri PJ, Talbot EA, Mtei L, Fordham von Reyn C. 2008. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int. J. Tuberc. Lung Dis. 12:1037-1041.
25. Peterson EM, et al. 1989. Direct identification of Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare from amplified primary cultures in BACTEC media using DNA probes. J. Clin. Microbiol. 27:1543-1547. (Pubitemid 19170160)
26. Samandari T, et al. 2011. 6-Month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 377:1588-1598.
27. Slutsky AM, et al. 1994. Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J. Clin. Microbiol. 32:1773-1778. (Pubitemid 24189573)
28. von Reyn CF, Jacobs NJ, Arbeit RD, Maslow JN, Niemczyk S. 1995. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J. Clin. Microbiol. 33:1008-1010.
29. von Reyn CF, et al. 2011. Disseminated tuberculosis in HIV infection: ineffective immunity, polyclonal disease and high mortality. Int. J. Tuberc. Lung Dis. 15:1-6.
30. von Reyn CF, et al. 2010. Prevention of tuberculosis in bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS 24:675-685.
31. Warren RM, et al. 2004. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169:610-614. (Pubitemid 38270897)
32. Wayne LG, Krasnow I. 1966. Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks. Am. J. Clin. Pathol. 45:769-771.
33. Yang ZH, et al. 1995. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J. Clin. Microbiol. 33:1064-1069.